Halofuginone hydrobromide is a quinazolinone derivative and a specific inhibitor of collagen type I synthesis primarily used in veterinary medicine for the prevention and treatment of coccidiosis. Beyond… Read more
Halofuginone hydrobromide is a quinazolinone derivative and a specific inhibitor of collagen type I synthesis primarily used in veterinary medicine for the prevention and treatment of coccidiosis. Beyond its application in livestock, researchers utilize this compound to study the inhibition of new blood vessel formation and its potential in fibrosis management. For robust analytical testing, laboratories require high-quality reference standards, including the active pharmaceutical ingredient, relevant impurities, and stable isotope labelled compounds such as Halofuginone 13C6 Hydrobromide. These materials are essential tools for pharmaceutical scientists performing impurity profiling, method validation, and quantitative analysis of metabolites. Utilizing precisely characterized reference standards ensures compliance with regulatory requirements and supports the accurate determination of trace-level contaminants during the development and quality control of pharmaceutical formulations.